Skip to main content

Ebola Cases On The Rise


Post By Max Gotlieb - Healthcare Reporter


Once again, there has been an outbreak of Ebola. This time the devastating virus has spread through the Congo. The World Health Organization (WHO) and other aid groups have taken notice. They seek to mitigate the effects of Ebola and stop the outbreak in its tracks. This occurrence of the virus is particularly concerning as there have been confirmed cases found in the city of Mbandaka, a densely-populated city that houses a busy river port.

Since its discovery in 1976 in the Democratic Republic of Congo (then Zaire), the virus has typically struck in remote areas, causing hemorrhagic fever among those infected. Between 2014 and 2016, there was a large outbreak of Ebola that killed nearly 11,000 people throughout West Africa.

A result of animals from tropical regions, Ebola has been traced to have originated from bats. Other possible hosts of the virus are the hunted African animals, namely monkeys and apes that are killed for food.

Unfortunately, Ebola is severely deadly and leads to vile results – often death. The virus kills 50 to 90 percent of those who contract it, an extremely high mortality rate. Effects such as high fever, black vomit, and black diarrhea cause extreme dehydration as the virus kills its victim. Extreme bleeding is another devastating effect of the virus.

Surprisingly, the disease is spread mostly through an uncommon way. Those who prepare the bodies of the dead for burial may contract the virus from being in contact with someone hosting it. Additionally, the virus may spread sexually. It may live within sperm cells even after the Ebola has been treated.

Although there is not a cure for Ebola, electrolyte and fluid replacement is an effective treatment against the intense bleeding, vomiting, and diarrhea. Experimental drugs such as ZMapp, favipiravir, and GS-5734 have been synthesized to stop the virus, though there is no definitive cure.

Scientists and doctors will continue their work to stop the outbreak. Experimental vaccines are still being tested and hopefully will be able to neutralize the dangerous virus in the near future.

The World Health Organization emphasizes that the risk of the disease is extremely high in Africa, but the threat of it spreading to other areas such as the United States is miniscule.

Comments

Popular posts from this blog

PALS Study Materials -Normal Pediatric Vital Signs

Study Reveals new Danger from E-Cigarette Flavorings

Electronic cigarettes, commonly known as e-cigs or vapes are a new and developing technology, yet little is known about the medical risk they pose to users. A new study offers insight into the effects of e-cigs. The flavoring used in nicotine juices may pose a risk to blood vessels and the cells within the heart. Although e-cigarettes were originally marketed as a cleaner alternative to smoking or a tool to help smokers quit, “They have also gained popularity among young people. According to the Centers for Disease Control and Prevention (CDC), there was an increase in middle and high school students using e-cigarettes from 2011 to 2016.” Ultimately, the study concluded that, “Our work and prior research have provided evidence that flavorings induce toxicity in the lung and cardiovascular systems. Flavorings are also a driver of youth tobacco use and sustained tobacco use among smokers." Due to the cardiovascular damage that e-cigs cause, it is recommended that medical professio…

Stop Taking That Aspirin You Were Told To Take

Taking a low-dose aspirin every day to prevent a heart attack or stroke is no longer recommended for most older adults, according to guidelines released Sunday.  After doctors said for decades that a daily 75 to 100 milligrams of aspirin could prevent cardiovascular problems, the American College of Cardiology and the American Heart Association reversed that idea.  A large clinical trial found a daily low-dose aspirin had no effect on prolonging life in healthy, elderly people and actually suggested the pills could be linked to major hemorrhages.
Sunday's recommendations say low-dose aspirin should not be given to prevent atherosclerotic cardiovascular disease on a routine basis to adults older than 70 or any adult at an increased risk of bleeding.  “Clinicians should be very selective in prescribing aspirin for people without known cardiovascular disease,” cardiologist Roger Blumenthal said in a statement. "It’s much more important to optimize lifestyle habits and control bl…